Natural Health Trends Corp.

NHTC

Consumer Cyclical Internet Retail

Natural Health Trends Corp.’s revenue for fiscal 2025 (year ended December 2025) was $39.8 million, down 7.42% from fiscal 2024.

Revenue
−20.2%
EPS
+32.5%
Free cash flow
−1,670.0%

Quarter to September 2026, against a year earlier

0.75 0.02 +2.74%
Market cap
$6.2M
P/E
n/m
Fwd P/E
75.1×
Dividend yield
53.3%
F-score
3/9
ROIC
0.00%
Net debt / EBITDA
17.0×
Dividend safety
20/100

A Cash Flow Statement is a financial report that details the cash inflows and outflows of a company over a specific period. It is divided into three sections: operating activities, investing activities, and financing activities. This statement helps assess the company’s liquidity, solvency, and overall financial health. By tracking cash movements, it provides insights into the company's ability to generate cash to fund operations, pay debts, and invest in growth. Businesses and investors use it to evaluate the sustainability of a company's cash flow and its financial stability.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Net Income
55.09 23.58 31.04 (5.61) 0.84 1.09 0.31 0.57 0.57 (0.88)
Depreciation & Amortization
0.39 0.54 0.42 2.15 0.41 0.30 0.20 0.16 0.13 0.11
Non Cash Items (Other)
0.45 (1.87) 0.36 0.94 2.87 1.53 1.26 1.09 0.81 1.00
Change in inventories
(0.85) 2.84 (3.88) 5.82 2.70 (1.55) 0.68 0.23 1.00 1.27
Accounts Payable Change
(0.71) (0.39) (0.12) (0.95) (0.10) 0.18 0.05 0.18 (0.09) (0.34)
Change in payables and accrued liability
(5.98) (8.45) 0.53 (12.39) 0.10 0.23 (1.39) (0.87) 0.25 (0.12)
Income tax paid
0.30 18.68 (2.08) (1.73) (0.31) (1.75) (1.40) (3.30) (3.86) (4.90)
Change in other assets and liabilities
4.48 (8.32) 3.44 (6.86) (4.62) 0.99 (4.57) (2.34) (2.17) (2.14)
Operating Cash Flow
53.17 26.61 29.71 (18.64) 1.89 1.02 (4.85) (4.28) (3.37) (6.00)
Capital expenditures
(0.90) (0.28) (0.21) (0.19) (0.21) (0.22) (0.14) (0.05) (0.06) (0.07)
Long-Term Investments Change (Net)
— — — — — — — — (30.02) 8.22
Investing cash flow
(0.90) (0.28) (0.21) (0.19) (0.21) (0.22) (0.14) (0.05) (30.07) 8.15
Equity Repurchase (Common, Net)
(23.70) — — (10.12) — — — — — —
Dividends Paid (Total)
(6.89) (17.22) (31.51) (7.34) (9.14) (9.14) (9.14) (9.21) (9.21) (9.21)
Financing cash flow
(30.59) (17.22) (31.51) (17.46) (9.14) (9.14) (9.14) (9.21) (9.21) (9.21)
Exchange Rate Adjustment
(0.67) 0.49 (0.81) 0.06 0.93 (0.18) (0.49) 0.01 0.01 0.31
Change in Cash
21.01 9.59 (2.83) (36.23) (6.53) (8.53) (14.62) (13.53) (42.65) (6.75)
Beginning Cash
104.91 128.88 138.48 135.65 99.43 92.89 84.37 69.75 56.22 13.57
Ending Cash
125.92 138.48 135.65 99.43 92.89 84.37 69.75 56.22 13.57 6.82
Stock Based Compensation
0.10 0.04 — — — — — 0.16 0.15 0.13
Dividends Paid (Common)
(6.89) (17.22) (31.51) (7.34) (9.14) (9.14) (9.14) (9.21) (9.21) (9.21)
Net Cash/Marketcap
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Assets Liabilities Change (Total)
(2.76) 4.36 (2.11) (16.12) (2.24) (1.89) (6.63) (6.10) (4.88) (6.22)
Investments Change (Net)
— — — — — — — — (30.02) 8.22
Issuance/Purchase of Shares
(23.70) — — (10.12) — — — — — —
Other line items
Revenue per Employee
2.01 1.33 1.25 0.51 0.43 0.43 0.35 0.32 0.32 0.33

Fold the line items

In millions of $ except per-share values · columns are period end dates · fundamentals updated 2 Nov 2026